MasterBrand, Inc.
MasterBrand, Inc. (MBC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mbc · stock forecast · 2 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$16.00
Consensus
$16.00
+89.1% upside
Low
$16.00
Median: $16 · Last Close: $8.46
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.88 | ↑ 5.00% |
1-day model range: $8.81–$8.96. Peak: $8.96 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -7.3% |
| 2028 | $8 | -11.0% |
| 2029 | $7 | -12.9% |
| 2030 | $7 | -14.0% |
| 2031 | — | -14.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MBC · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-05-07 | Loop Capital | Maintains | Buy→Buy |
| 2025-04-28 | Loop Capital | Maintains | Buy→Buy |
| 2025-04-14 | Zelman & Assoc | Downgrade ↓ | Neutral→Underperform |
| 2025-02-19 | Loop Capital | Maintains | Buy→Buy |
| 2024-10-17 | Loop Capital | Maintains | Buy→Buy |
| 2023-07-24 | Loop Capital | Maintains | Buy→Buy |
| 2023-05-10 | Loop Capital | Upgrade ↑ | Hold→Buy |
Wall Street analysts have recently issued updated ratings on MasterBrand, Inc. (MBC) stock. Of the recent 7 rating actions, 1 were upgrades and 1 were downgrades. 2 analysts currently cover MBC.
Analyst Recommendation Trends
MBC analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.7B
↑ 0.7% YoY
Revenue Next Year
$2.8B
↑ 1.3% YoY
EPS This Year
$1.44
EPS Next Year
$1.54
↑ 6.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast MBC EPS of $1.44 for the current fiscal year, based on estimates from 2 analysts. The MBC revenue forecast is $2.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MBC stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MBC price target is $16.00 (+89.1% upside), with an analyst consensus of Buy.
The MBC short-term stock prediction for tomorrow is $8.88 (+5.00%). The MBC stock price prediction for 2027 estimates an average of $8. The MBC stock prediction for 2030 projects a range of $7–$8.
MasterBrand, Inc. trades on NYSE under the ticker MBC. The MBC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
MBC forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month MBC price target is $16.00, with a high forecast of $16.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies +89.1% potential upside from the current price of $8.46.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.